150 related articles for article (PubMed ID: 34057311)
1. Isolation, Behavioral Changes, and Low Seroprevalence of SARS-CoV-2 Antibodies in Patients With Systemic Lupus Erythematosus or Rheumatoid Arthritis.
Ammitzbøll C; Andersen JB; Vils SR; Mistegaard CE; Mikkelsen S; Erikstrup C; Thomsen MK; Hauge EM; Troldborg A
Arthritis Care Res (Hoboken); 2022 Nov; 74(11):1780-1785. PubMed ID: 34057311
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of SARS-CoV-2-specific antibodies and vaccination-related adverse events in systemic lupus erythematosus and rheumatoid arthritis.
Wang P; Ni J; Chu YY; Chen QQ; Wu GC; Fang Y; Chen C; Zhang RD; Jiang LQ; Zhao Y; Fang X; He J; Wang DG; Wang GH; Pan HF
Biomed Pharmacother; 2022 Jun; 150():112997. PubMed ID: 35486976
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 prognosis in systemic lupus erythematosus compared with rheumatoid arthritis and spondyloarthritis: results from the CONTROL-19 Study by the Italian Society for Rheumatology.
Scirocco C; Ferrigno S; Andreoli L; Fredi M; Lomater C; Moroni L; Mosca M; Raffeiner B; Carrara G; Landolfi G; Rozza D; Zanetti A; Scirè CA; Sebastiani GD
Lupus Sci Med; 2023 Oct; 10(2):. PubMed ID: 37848262
[TBL] [Abstract][Full Text] [Related]
4. Staff SARS-CoV-2 Seroprevalence and Mental Health as Key Factors in University Response to COVID-19 Pandemic.
Lopes DG; Henriques AR; Santos-Dias M; Nunes-da-Silva C; Gonçalves J; de Sousa RD; Abdulghani S; Eletério J; Braga SJ; Soares H; Branco JC; Canhão H; Rodrigues AM
Front Public Health; 2021; 9():689919. PubMed ID: 34222187
[No Abstract] [Full Text] [Related]
5. The effect of suffering from rheumatoid arthritis, systemic lupus erythematosus, and back pain on sexual functioning and marital satisfaction in Iran.
Yazdi F; Shakibi MR; Gharavi Roudsari E; Nakhaee N; Salajegheh P
Int J Rheum Dis; 2021 Mar; 24(3):373-379. PubMed ID: 33452762
[TBL] [Abstract][Full Text] [Related]
6. Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis.
Bartels LE; Ammitzbøll C; Andersen JB; Vils SR; Mistegaard CE; Johannsen AD; Hermansen MF; Thomsen MK; Erikstrup C; Hauge EM; Troldborg A
Rheumatol Int; 2021 Nov; 41(11):1925-1931. PubMed ID: 34476603
[TBL] [Abstract][Full Text] [Related]
7. Impact of the mandatory confinement during the first wave of the SARS-CoV-2/COVID-19 pandemic in Portuguese patients with rheumatoid arthritis: results from the COVID in RA (COVIDRA) survey.
Araújo FC; Gonçalves NP; Mourão AF
Acta Reumatol Port; 2021; 46(2):126-133. PubMed ID: 34226432
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular health worsening in patients with autoimmune rheumatological diseases during the COVID-19 pandemic.
Galarza-Delgado DA; Azpiri-Lopez JR; Colunga-Pedraza IJ; Cardenas-de la Garza JA; Gonzalez-Gonzalez V; Beltran-Aguilar VM; Arias-Peralta AG; De Avila-Gonzalez N; Guajardo-Jauregui N
Clin Rheumatol; 2023 Oct; 42(10):2677-2690. PubMed ID: 36627529
[TBL] [Abstract][Full Text] [Related]
9. Asymptomatic SARS-CoV-2 seropositivity: patients with childhood-onset rheumatic diseases versus healthy children.
Haslak F; Ozbey D; Yildiz M; Adrovic A; Sahin S; Koker O; Aliyeva A; Guliyeva V; Yalcin G; Inanli G; Kocazeybek BS; Kasapcopur O; Barut K
Clin Rheumatol; 2022 May; 41(5):1523-1533. PubMed ID: 35044502
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients.
Zen M; Fuzzi E; Astorri D; Saccon F; Padoan R; Ienna L; Cozzi G; Depascale R; Zanatta E; Gasparotto M; Benvenuti F; Bindoli S; Gatto M; Felicetti M; Ortolan A; Campaniello D; Larosa M; Lorenzin M; Ramonda R; Sfriso P; Schiavon F; Iaccarino L; Doria A
J Autoimmun; 2020 Aug; 112():102502. PubMed ID: 32527675
[TBL] [Abstract][Full Text] [Related]
11. Health care and burden of illness in systemic lupus erythematosus compared to rheumatoid arthritis: results from the National Database of the German Collaborative Arthritis Centres.
Zink A; Fischer-Betz R; Thiele K; Listing J; Huscher D; Gromnica-Ihle E; Specker C; Schneider M;
Lupus; 2004; 13(7):529-36. PubMed ID: 15352425
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence and clinical outcomes of SARS-CoV-2 in paediatric patients with rheumatic disease.
Walters HM; Mian Z; Thomas L; Cerise J; Eberhard BA; Pagano E; Gottlieb BS; Steigerwald K; Hui-Yuen JS
Rheumatology (Oxford); 2022 Jun; 61(SI2):SI112-SI119. PubMed ID: 34599820
[TBL] [Abstract][Full Text] [Related]
13. Illness perceptions and psychological distress associated with physical health-related quality of life in primary Sjögren's syndrome compared to systemic lupus erythematosus and rheumatoid arthritis.
Kotsis K; Voulgari PV; Tsifetaki N; Drosos AA; Carvalho AF; Hyphantis T
Rheumatol Int; 2014 Dec; 34(12):1671-81. PubMed ID: 24769916
[TBL] [Abstract][Full Text] [Related]
14. Toxoplasma gondii: bystander or cofactor in rheumatoid arthritis.
Fischer S; Agmon-Levin N; Shapira Y; Porat Katz BS; Graell E; Cervera R; Stojanovich L; Gómez Puerta JA; Sanmartí R; Shoenfeld Y
Immunol Res; 2013 Jul; 56(2-3):287-92. PubMed ID: 23553228
[TBL] [Abstract][Full Text] [Related]
15. Systemic lupus erythematosus flare during SARS-CoV-2 infection: Report of 3 cases presented during the fourth wave of the pandemic in Colombia.
Naranjo-Millán JA; Bedoya-Joaqui V; Cañas CA
Int J Rheum Dis; 2023 Sep; 26(9):1807-1810. PubMed ID: 36880687
[TBL] [Abstract][Full Text] [Related]
16. Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry.
Glintborg B; Jensen DV; Engel S; Terslev L; Pfeiffer Jensen M; Hendricks O; Ostergaard M; Horskjær Rasmussen S; Adelsten T; Colic A; Danebod K; Kildemand M; Loft AG; Munk HL; Pedersen JK; Østgård RD; Møller Sørensen C; Krogh NS; Agerbo J; Ziegler C; Hetland M
RMD Open; 2021 Jan; 7(1):. PubMed ID: 33402443
[TBL] [Abstract][Full Text] [Related]
17. Impact of the first wave of the COVID-19 pandemic on systemic lupus erythematosus patients: Results from a multi-center prospective cohort.
Kasturi S; Price LL; Paushkin V; Salmon JE; McAlindon TE; Mandl LA
Lupus; 2021 Oct; 30(11):1747-1755. PubMed ID: 34284676
[TBL] [Abstract][Full Text] [Related]
18. Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.
He F; Luo Q; Lei M; Fan L; Shao X; Hu K; Qin S; Yu N; Cao J; Yang L
Clin Rheumatol; 2020 Sep; 39(9):2803-2810. PubMed ID: 32725351
[TBL] [Abstract][Full Text] [Related]
19. Medication Adherence of Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis Considering the Psychosocial Factors, Health Literacy and Current Life Concerns of Patients.
Shenavandeh S; Mani A; Eazadnegahdar M; Nekooeian A
Curr Rheumatol Rev; 2021; 17(4):412-420. PubMed ID: 33645485
[TBL] [Abstract][Full Text] [Related]
20. High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study.
Loarce-Martos J; García-Fernández A; López-Gutiérrez F; García-García V; Calvo-Sanz L; Del Bosque-Granero I; Terán-Tinedo MA; Boteanu A; Bachiller-Corral J; Vázquez-Díaz M
Rheumatol Int; 2020 Dec; 40(12):2015-2021. PubMed ID: 32945944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
